Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 October 2024
iCAN Book Cover

The Centre for Teaching and Learning recently unveiled the fourth volume of the Initiative for African Narratives (iCAN), a vibrant celebration of diverse voices at the University of the Free State (UFS). This latest anthology features 48 stories presented in 10 of South Africa’s official languages: Afrikaans, English, isiNdebele, isiXhosa, isiZulu, Sesotho, Sepedi, siSwati, Tshivenda and Xitsonga. Contributors include Kovsie writers from all three UFS campuses, reflecting the university’s rich linguistic and cultural diversity.

“This initiative forms part of the university’s commitment to promoting multilingualism while providing a platform for a wide array of narratives,” said Dr Peet van Aardt, iCAN Coordinator. “Every student at the university has stories to tell – whether drawn from their personal experiences or shaped by their imagination.”

The launch, held on the Bloemfontein Campus, attracted around 150 students. Attendees were treated to musical performances by the Conlaures Choir, conducted by Omphemetse Phaswana, and a captivating saxophone solo by Thabo Dlamini from the Odeion School of Music. Representatives from the Academy for Multilingualism and African Languages Press were also present, underscoring the event’s focus on the intersection of language and expression.

This year's anthology, iCAN Vol. 4, is the ninth publication under the iCAN initiative in the past seven years. In addition to these collaborative anthologies, iCAN has also published several standalone works by solo student authors. Coordinated by senior student writer Siphila Dlamini, this volume showcases some of the finest writing talent across the UFS campuses.

Student of the year

Shortly after the iCAN launch, the Office of the Executive Dean of Student Affairs announced that Siphila Dlamini had been awarded the prestigious EDSA Student of the Year 2024 title. His contributions to student success and well-being were lauded as being aligned with the university’s strategic objectives.

Currently completing his Postgraduate Diploma in Governance and Political Transformation, Siphila plans to pursue a master’s degree next year. Reflecting on the award, he said, “This recognition, stemming from my work with iCAN, is a humbling reminder of the power of storytelling to transcend boundaries. It reaffirms my belief that by amplifying diverse voices and fostering creativity, we can spark change, inspire growth, and leave an indelible mark on our collective narrative.”

Siphila’s accolade marks the second consecutive win for an iCAN writer. Last year, the award was bestowed upon Tlotlisang David Mhlambiso from the Faculty of Education, further highlighting the initiative’s role in nurturing outstanding talent.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept